Plain-English translation of NCT06099158 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether HeartLogic, a feature in certain heart rhythm devices, can help doctors manage heart failure more effectively. HeartLogic is designed to detect early warning signs of worsening heart failure by monitoring your heart's activity. The trial will compare patients who receive care guided by these device alerts against those who receive standard heart failure care.
Doctors currently manage heart failure by seeing patients at regular appointments and relying on symptoms that patients report. This new treatment approach aims to catch problems earlier, before symptoms get worse, by using information from your device to alert your care team.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either receive care guided by HeartLogic alerts or standard heart failure care. If you are in the alert group, your care team will contact you whenever your device sends an alert so they can decide if any treatment changes are needed. There are no mandatory in-person visits scheduled — your information will be gathered from Danish health records and your device.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Denmark